The EdU assay also confirmed that NVP-BEZ235 inhibited the proliferation of HCC cells, and the inhibitory effect was significantly enhanced after inhibiting IL-6 (Fig. 4B). The gene discussed is IL6; the disease is hepatocellular carcinoma.